Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn F Pierce

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Journal of Thrombosis and Haemostasis : JTH|December 17, 2020
Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting databaseSteven W Pipe, Rebecca Kruse-Jarres, Johnny N Mahlangu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 11, 2006
Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia BHaiyan Jiang, Glenn F Pierce, Margareth C Ozelo, et al.
Blood|July 27, 2006
Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapyHaiyan Jiang, Linda B Couto, Susannah Patarroyo-White, et al.
Research and Practice in Thrombosis and Haemostasis|February 3, 2025
Adeno-associated virus-based gene therapy for hemophilia-addressing the gapsWolfgang Miesbach, Paul Batty, Pratima Chowdary, et al.
Blood|July 5, 2007
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liverFederico Mingozzi, Nicole C Hasbrouck, Etiena Basner-Tschakarjan, et al.
Blood|August 6, 2009
Enhanced efficacy of recombinant FVIII in noncovalent complex with PEGylated liposome in hemophilia A miceJunliang Pan, Tongyao Liu, Ji-Yun Kim, et al.
Blood|September 11, 2020
Activity of transgene-produced B-domain-deleted factor VIII in human plasma following AAV5 gene therapySteffen Rosen, Stefan Tiefenbacher, Mary Robinson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2024
Long-term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post-treatmentEmily Symington, Savita Rangarajan, Will Lester, et al.
Journal of Virology|November 25, 2005
Novel caprine adeno-associated virus (AAV) capsid (AAV-Go.1) is closely related to the primate AAV-5 and has unique tropism and neutralization propertiesAlejandra E Arbetman, Michael Lochrie, Shangzhen Zhou, et al.
Virology|June 30, 2006
Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5Michael A Lochrie, Gwen P Tatsuno, Alejandra E Arbetman, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Journal of Thrombosis and Haemostasis : JTH|December 17, 2020
Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting databaseSteven W Pipe, Rebecca Kruse-Jarres, Johnny N Mahlangu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 11, 2006
Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia BHaiyan Jiang, Glenn F Pierce, Margareth C Ozelo, et al.
Blood|July 27, 2006
Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapyHaiyan Jiang, Linda B Couto, Susannah Patarroyo-White, et al.
Research and Practice in Thrombosis and Haemostasis|February 3, 2025
Adeno-associated virus-based gene therapy for hemophilia-addressing the gapsWolfgang Miesbach, Paul Batty, Pratima Chowdary, et al.
Blood|July 5, 2007
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liverFederico Mingozzi, Nicole C Hasbrouck, Etiena Basner-Tschakarjan, et al.
Blood|August 6, 2009
Enhanced efficacy of recombinant FVIII in noncovalent complex with PEGylated liposome in hemophilia A miceJunliang Pan, Tongyao Liu, Ji-Yun Kim, et al.
Blood|September 11, 2020
Activity of transgene-produced B-domain-deleted factor VIII in human plasma following AAV5 gene therapySteffen Rosen, Stefan Tiefenbacher, Mary Robinson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2024
Long-term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post-treatmentEmily Symington, Savita Rangarajan, Will Lester, et al.
Journal of Virology|November 25, 2005
Novel caprine adeno-associated virus (AAV) capsid (AAV-Go.1) is closely related to the primate AAV-5 and has unique tropism and neutralization propertiesAlejandra E Arbetman, Michael Lochrie, Shangzhen Zhou, et al.
Virology|June 30, 2006
Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5Michael A Lochrie, Gwen P Tatsuno, Alejandra E Arbetman, et al.
Pageof 10